Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases

Recombinant activated factor VII (rFVIIa) is the bypassing agent used in the first-line hemostatic therapy for acquired hemophilia A (AHA); however, the occurrence of thrombotic complications in rFVIIa-treated AHA patients was recently reported to be 2.9–6.5%. Therefore, the investigation of the pro...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Gen Med
Main Authors: Saito, Makoto, Kanaya, Minoru, Izumiyama, Koh, Mori, Akio, Irie, Tatsuro, Tanaka, Masanori, Morioka, Masanobu, Ieko, Masahiro
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2016
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5098745/
https://ncbi.nlm.nih.gov/pubmed/27843336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJGM.S118422
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker